May 7, 2026 12:14 PM
Moderna’s mRNA flu vaccine outperforms standard shot in late-stage trial
Moderna's mRNA-based seasonal flu vaccine worked better than conventional flu shots in a late-stage international trial of more than 40,000 adults aged 50 and older, researchers reported on Wednesday. The vaccine is currently under review by the U.S...
